Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review
ABSTRACT Objective: To evaluate the available evidence comparing the use of the bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) regimen for 6 months with that of standard-of-care regimens for patients with multidrug-resistant or rifampin-resistant tuberculosis (MDR/RR-TB). Methods: Th...
Saved in:
| Main Authors: | Denise Rossato Silva, Flávia Fonseca Fernandes, Juliana Carvalho Ferreira, Wanderley Bernando, Margareth Maria Pretti Dalcolmo, Fernanda Dockhorn Costa Johansen, Fernanda Carvalho de Queiroz Mello |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Pneumologia e Tisiologia
2025-01-01
|
| Series: | Jornal Brasileiro de Pneumologia |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132024000601500&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse events reported with BPaL and BPaLM regimens in drug-resistant tuberculosis
by: Kannan Sridharan, et al.
Published: (2025-08-01) -
Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in Pakistan
by: M.A. Khan, et al.
Published: (2024-11-01) -
Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials
by: J. Nedelman, et al.
Published: (2025-08-01) -
Recent advancements in tuberculosis (TB) treatment regimens
by: Shyamala Ravikoti, et al.
Published: (2025-02-01) -
The efficacy of moxifloxacin in patients with bacterial keratitis
by: Janićijević Katarina M., et al.
Published: (2018-01-01)